Lamin B2 regulates nuclear remodeling in cardiomyocyte terminal differentiation
Lamin B2 调节心肌细胞终末分化中的核重塑
基本信息
- 批准号:10372035
- 负责人:
- 金额:$ 38.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAdolescentAdultApoptosisBirthCaliberCardiac MyocytesCell CycleCell DeathCell NucleusCellsCessation of lifeChildhoodChromatinChromatin StructureChronicCommunicationCytoplasmDevelopmentDiseaseEventGene ExpressionGene Expression ProfilingGene SilencingGene TransferGenesGenetic TranscriptionGrowthHealthHeartHeart DiseasesHeart InjuriesHeart failureHumanInjuryInterdisciplinary StudyIntermediate FilamentsIschemiaLeadMammalsMicroscopyMitosisModelingMolecularMorbidity - disease rateMusMyocardialNatural regenerationNeonatalNuclearNuclear ImportNuclear LaminaNuclear PoreOutcomePatientsPloidiesPolyploidyPredispositionProgressive DiseasePublic HealthRegenerative MedicineRegenerative capacityReperfusion TherapyResearchResistanceResolutionRoleSignal TransductionSignaling MoleculeSpecificityTechniquesTestingViralWithdrawalWorkcardiac regenerationcardiogenesiscdc Genesgain of functionheart functionin vivoinnovationknockout genelamin B2loss of functionmortalitymouse modelmyocardial injuryneonatal micenew therapeutic targetnovel therapeuticsnucleocytoplasmic transportsingle-cell RNA sequencingtranscriptome sequencing
项目摘要
ABSTRACT
Heart disease is the leading cause of morbidity and mortality worldwide. Different types of heart injury lead to
the development of heart failure, a chronically progressive disease. Heart failure is characterized by increased
cardiomyocyte death and insufficient regeneration of new ones. As such, increasing cardiomyocyte
regeneration and decreasing death represent targets for new therapies. This application is for developing a
transformative paradigm connecting these important cellular mechanisms with nuclear remodeling in
cardiomyocyte differentiation.
Our new results show that when cardiomyocytes differentiate they decrease the number of nuclear
pores (NP). NP are large channels of > 100 nm outer diameter for communication between the nucleus and
the cytoplasm. NP, along with the nuclear lamina (NL), function in regulating the nuclear transport of signaling
molecules and chromatin organization. Although heart failure alters nuclear transport, the structural and
functional changes of NL and NP changes during terminal differentiation are unknown. To determine the
molecular mechanisms directing the decrease of NP, we have used single-cell transcriptional profiling, which
identified a decrease in expression of lamin B2 (Lmnb2), an intermediate filament and component of the NL,
during cardiomyocyte differentiation. Our new results show that Lmnb2 gene knockout in cardiomyocytes
blocks M-phase, that is, nuclei do not divide, and instead become polyploid. In addition, the M-phase block
decreases NP incorporation. As a result, although the DNA contents of nuclei (ploidy) increases, the number of
NP decreases by 50%. The lower NP number identifies a central event in nuclear remodeling, as it indicates
not only altered nuclear transport, but also altered chromatin structure. Together, this could explain the
decreased ability of terminally differentiated cardiomyocytes to activate cell cycle genes and their increased
susceptibility to cell death.
This proposal aims to develop a new mechanistic paradigm of nuclear remodeling in cardiomyocyte
differentiation, which is synergistic with recent advances in characterizing chromatin changes. We will test the
central hypothesis that decreased Lmnb2 gene expression is a central mechanism of nuclear
remodeling in cardiomyocyte differentiation. We have assembled an interdisciplinary research team and
prepared innovative techniques (super-resolution microscopy, single-cell RNAseq, ATACseq) that, combined
with cardiomyocyte-specific Lmnb2flox inactivation and viral expression of Lmnb2, will enable us to determine its
role in nuclear remodeling in cardiomyocyte differentiation.
The anticipated results will enable future research toward understanding and targeting nuclear
remodeling in myocardial development, regeneration, and disease. This will be broadly significant for patients
with congenital and acquired heart diseases.
抽象的
心脏病是全世界发病和死亡的主要原因。不同类型的心脏损伤会导致
心力衰竭的发展,一种慢性进行性疾病。心力衰竭的特点是增加
心肌细胞死亡和新细胞再生不足。因此,增加心肌细胞
再生和减少死亡是新疗法的目标。该应用程序用于开发
将这些重要的细胞机制与核重塑联系起来的变革范式
心肌细胞分化。
我们的新结果表明,当心肌细胞分化时,它们会减少核细胞的数量
孔隙(NP)。 NP 是外径大于 100 nm 的大通道,用于细胞核和细胞核之间的通讯
细胞质。 NP 与核纤层 (NL) 一起调节信号的核运输
分子和染色质组织。尽管心力衰竭改变了核运输,但结构和
终末分化过程中NL和NP变化的功能变化尚不清楚。确定
为了确定指导 NP 减少的分子机制,我们使用了单细胞转录分析,
发现核纤层蛋白 B2 (Lmnb2) 的表达减少,核纤层蛋白 B2 是一种中间丝,也是 NL 的组成部分,
心肌细胞分化期间。我们的新结果表明心肌细胞中的 Lmnb2 基因敲除
阻断 M 期,即细胞核不分裂,而是变成多倍体。此外,M相块
减少 NP 掺入。结果,虽然细胞核的 DNA 含量(倍性)增加,但
NP 减少 50%。较低的 NP 数标识了核重塑中的中心事件,因为它表明
不仅改变了核运输,还改变了染色质结构。综合起来,这可以解释
终末分化心肌细胞激活细胞周期基因的能力下降及其增加
对细胞死亡的敏感性。
该提案旨在开发心肌细胞核重塑的新机制范式
分化,这与表征染色质变化的最新进展具有协同作用。我们将测试
中心假设:Lmnb2 基因表达减少是核细胞凋亡的一个中心机制。
心肌细胞分化的重塑。我们组建了一支跨学科的研究团队
准备了创新技术(超分辨率显微镜、单细胞 RNAseq、ATACseq),结合
心肌细胞特异性 Lmnb2flox 失活和 Lmnb2 的病毒表达,将使我们能够确定其
心肌细胞分化中核重塑的作用。
预期结果将使未来的研究能够理解和瞄准核
心肌发育、再生和疾病的重塑。这对于患者来说具有广泛的意义
患有先天性和后天性心脏病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bernhard Kuhn其他文献
Bernhard Kuhn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bernhard Kuhn', 18)}}的其他基金
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot
法洛四联症中β受体阻滞剂重新激活心肌细胞分裂的机制临床试验
- 批准号:
10427418 - 财政年份:2021
- 资助金额:
$ 38.22万 - 项目类别:
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot
法洛四联症中β受体阻滞剂重新激活心肌细胞分裂的机制临床试验
- 批准号:
10630817 - 财政年份:2021
- 资助金额:
$ 38.22万 - 项目类别:
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot
法洛四联症中β受体阻滞剂重新激活心肌细胞分裂的机制临床试验
- 批准号:
10840490 - 财政年份:2021
- 资助金额:
$ 38.22万 - 项目类别:
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot
法洛四联症中β受体阻滞剂重新激活心肌细胞分裂的机制临床试验
- 批准号:
10295053 - 财政年份:2021
- 资助金额:
$ 38.22万 - 项目类别:
Lamin B2 regulates nuclear remodeling in cardiomyocyte terminal differentiation
Lamin B2 调节心肌细胞终末分化中的核重塑
- 批准号:
10579284 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients
儿科患者心肌细胞增殖下降及其逆转的量化
- 批准号:
10413070 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients
儿科患者心肌细胞增殖下降及其逆转的量化
- 批准号:
10625836 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients
儿科患者心肌细胞增殖下降及其逆转的量化
- 批准号:
10191031 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Myofibril disassembly during neonatal heart muscle cell proliferation
新生儿心肌细胞增殖过程中的肌原纤维解体
- 批准号:
8780671 - 财政年份:2010
- 资助金额:
$ 38.22万 - 项目类别:
Myofibril disassembly during neonatal heart muscle cell proliferation
新生儿心肌细胞增殖过程中的肌原纤维解体
- 批准号:
8386967 - 财政年份:2010
- 资助金额:
$ 38.22万 - 项目类别:
相似国自然基金
自然接触对青少年网络问题行为的作用机制及其干预
- 批准号:72374025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
大气污染物对青少年心理健康的影响机制研究
- 批准号:42377437
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
新发现青少年痛风易感基因OTUD4对痛风炎症的影响及调控机制研究
- 批准号:82301003
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人际压力影响青少年抑郁发展的心理与神经机制:基于自我意识的视角
- 批准号:32371118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
巨噬细胞M1型极化促进脂肪细胞肥大并抑制前脂肪细胞成脂分化在双酚F致青少年腹型肥胖中的作用机制研究
- 批准号:82373615
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
At the right time and place – identifying epigenetic and molecular determinants of a developmental learning window
在正确的时间和地点 – 识别发育学习窗口的表观遗传和分子决定因素
- 批准号:
10575177 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
Combined bromodomain and CDK4/6 inhibition in NUT Carcinoma and other solid tumors
溴结构域和 CDK4/6 联合抑制 NUT 癌和其他实体瘤
- 批准号:
10577265 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
Population-level and mechanistic dissection of 17q21 structural variant association with psychiatric traits
17q21 结构变异与精神特征关联的群体水平和机制剖析
- 批准号:
10732393 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
Microglial contribution to Down Syndrome Neuropathology
小胶质细胞对唐氏综合症神经病理学的贡献
- 批准号:
10566660 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别: